H. B. Fuller Company (NYSE:FUL) has been assigned an average recommendation of “Hold” from the six brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $51.67.
A number of equities research analysts recently weighed in on FUL shares. Zacks Investment Research raised shares of H. B. Fuller Company from a “sell” rating to a “buy” rating and set a $57.00 target price on the stock in a research note on Monday, March 27th. Citigroup Inc. raised their target price on shares of H. B. Fuller Company from $55.00 to $59.00 and gave the company a “buy” rating in a research note on Tuesday, April 4th. Finally, BidaskClub raised shares of H. B. Fuller Company from a “hold” rating to a “buy” rating in a research note on Saturday, June 10th.
ILLEGAL ACTIVITY WARNING: This article was reported by WKRB News and is the property of of WKRB News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.wkrb13.com/markets/2231085/brokerages-set-h-b-fuller-company-ful-pt-at-51-67.html.
Shares of H. B. Fuller Company (NYSE:FUL) traded up 0.85% during midday trading on Monday, hitting $52.28. 341,486 shares of the company traded hands. The stock has a 50 day moving average of $51.89 and a 200-day moving average of $50.32. H. B. Fuller Company has a 52 week low of $41.52 and a 52 week high of $54.32. The stock has a market capitalization of $2.64 billion, a PE ratio of 22.36 and a beta of 1.65.
H. B. Fuller Company (NYSE:FUL) last announced its earnings results on Wednesday, March 29th. The specialty chemicals company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.03. The business had revenue of $503.32 million for the quarter, compared to the consensus estimate of $485.17 million. H. B. Fuller Company had a net margin of 5.65% and a return on equity of 13.81%. During the same period last year, the firm posted $0.43 earnings per share. Equities analysts forecast that H. B. Fuller Company will post $2.66 earnings per share for the current fiscal year.
In other H. B. Fuller Company news, VP David W. Moorman sold 1,683 shares of H. B. Fuller Company stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $52.76, for a total transaction of $88,795.08. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Steven Kenny sold 7,000 shares of H. B. Fuller Company stock in a transaction that occurred on Friday, March 31st. The stock was sold at an average price of $52.50, for a total transaction of $367,500.00. The disclosure for this sale can be found here. Insiders have sold 13,866 shares of company stock worth $716,760 over the last three months. Insiders own 3.10% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. increased its position in H. B. Fuller Company by 10,635.2% in the first quarter. BlackRock Inc. now owns 6,217,806 shares of the specialty chemicals company’s stock valued at $320,590,000 after buying an additional 6,159,886 shares during the period. Vanguard Group Inc. increased its position in H. B. Fuller Company by 7.5% in the first quarter. Vanguard Group Inc. now owns 5,055,505 shares of the specialty chemicals company’s stock valued at $260,662,000 after buying an additional 351,478 shares during the period. Dimensional Fund Advisors LP increased its position in H. B. Fuller Company by 4.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,004,463 shares of the specialty chemicals company’s stock valued at $103,353,000 after buying an additional 80,277 shares during the period. Champlain Investment Partners LLC increased its position in H. B. Fuller Company by 53.9% in the first quarter. Champlain Investment Partners LLC now owns 1,664,330 shares of the specialty chemicals company’s stock valued at $85,813,000 after buying an additional 582,945 shares during the period. Finally, Silvercrest Asset Management Group LLC increased its position in H. B. Fuller Company by 25.4% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 1,610,856 shares of the specialty chemicals company’s stock valued at $77,820,000 after buying an additional 326,127 shares during the period. 93.71% of the stock is currently owned by hedge funds and other institutional investors.
About H. B. Fuller Company
H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2231085/brokerages-set-h-b-fuller-company-ful-pt-at-51-67.html
Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.